InvVax, Inc.

InvVax is a vaccine development company. Our initial product is a universal influenza vaccine that will disrupt the $5.8 billion global flu vaccine market.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Pasadena, CA, USA
  • Currency USD
  • Founded January 2013
  • Employees 1
  • Incorporation Type C-corp
  • Website inv-vax.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free